To rule out severe COVID-19 as a mediator of low ALT and post COVID-19 CHF, we performed an additional analysis excluding patients who were hospitalized in ICU at any point (n = 288) or in a ward for more than 10 days due to COVID-19 (n = 973). The gene discussed is GPT; the disease is COVID-19.